Recruiting Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies NCT07565220 Conditions Acute Leukemia, Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), +19 more Locations UMPC Hillman Cancer Center — Pittsburgh, Pennsylvania, United States View Trial Details
Recruiting Identification of MPN-specific Antigens and Anti-MPN TCRs in Myeloproliferative Neoplasm NCT07590986 Conditions Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +11 more Locations de Duve Institute, UCLouvain — Brussels, Woluwe, Belgium View Trial Details
Recruiting A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation NCT06859424 Conditions AML (Acute Myelogenous Leukemia), Acute Leukemia (Category), Acute Lymphoid Leukemia (ALL), +36 more Locations University of Alabama Birmingham — Birmingham, Alabama, United States City of Hope — Duarte, California, United States Stanford — Palo Alto, California, United States University of Miami — Miami, Florida, United States View all 13 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Safety of Flonoltinib Maleate Tablets for the Treatment of Patients With Myeloproliferative NCT05153343 Conditions Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more Locations West China Hospital Sichuan University — Chengdu, Sichuan, China View Trial Details
Completed Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients NCT04243122 Conditions Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +22 more Locations The Ottawa Hospital — Ottawa, Ontario, Canada View Trial Details
